CanadaBis Capital Net Income Over Time
| CANB Stock | CAD 0.03 0.01 16.67% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out CanadaBis Capital Performance and CanadaBis Capital Correlation. CanadaBis |
Cross Equities Net Income Analysis
Compare CanadaBis Capital and related stocks such as Good Shroom, Telo Genomics Corp, and Avant Brands Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MUSH | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (1.6 M) | (452.1 K) | 40.6 K | (412.3 K) | (474.2 K) | (497.9 K) |
| TELO | (118.2 K) | (118.2 K) | (118.2 K) | (37.2 K) | (108.7 K) | (70.1 K) | (9.9 M) | (4.7 M) | (1.1 M) | (1.2 M) | (1.1 M) | (2.1 M) | (2.8 M) | (2.7 M) | (2.7 M) | (2.4 M) | (2.6 M) |
| AVNT | (15.4 K) | (15.4 K) | (15.4 K) | (167.2 K) | (650.2 K) | 51.2 K | (207 K) | (24.5 K) | (10.5 M) | (9.8 M) | (10.2 M) | (11.2 M) | (7.5 M) | (5.1 M) | (22.6 M) | (20.3 M) | (19.3 M) |
| AVCR | (12.6 K) | (306.6 K) | 283.4 K | (733.9 K) | (2.2 M) | (2.8 M) | (2.6 M) | (2.7 M) | (4.1 M) | (2.1 M) | (1.2 M) | (1.7 M) | (818.2 K) | (701.2 K) | (669 K) | (602.1 K) | (632.2 K) |
| KNE | (405.5 K) | (1.2 M) | (1.5 M) | (1.4 M) | (1.6 M) | (1.7 M) | (2.5 M) | (2.8 M) | (3.3 M) | (960.2 K) | (3.7 M) | (4.6 M) | (3.9 M) | (5 M) | 6.1 M | 5.5 M | 5.8 M |
CanadaBis Capital and related stocks such as Good Shroom, Telo Genomics Corp, and Avant Brands Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in CanadaBis Capital financial statement analysis. It represents the amount of money remaining after all of CanadaBis Capital operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| CanadaBis Capital | CANB |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 255C Clearview Drive, |
| Exchange | TSX Venture Exchange |
CAD 0.025
Additional Tools for CanadaBis Stock Analysis
When running CanadaBis Capital's price analysis, check to measure CanadaBis Capital's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CanadaBis Capital is operating at the current time. Most of CanadaBis Capital's value examination focuses on studying past and present price action to predict the probability of CanadaBis Capital's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CanadaBis Capital's price. Additionally, you may evaluate how the addition of CanadaBis Capital to your portfolios can decrease your overall portfolio volatility.